Kaken Pharmaceutical Co Ltd (4521):企業の財務・戦略的SWOT分析

◆英語タイトル:Kaken Pharmaceutical Co Ltd (4521) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8767
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kaken Pharmaceutical Co Ltd (4521) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kaken Pharmaceutical Co Ltd (Kaken Pharma) is a pharmaceutical company that conducts research and develops drugs, agrochemicals, medical equipment and animal health products. The company offers solutions in the fields of orthopedics, dermatology, immunology, inflammation, allergies, fungal infection and pain relief. It offers streptomycin and various antifungal agents. Kaken Pharma also offers fungicides, rice herbicide, anti-coccidial for chickens and polypeptide antibiotic. The company conducts research activities in inflammation and immunology, pain relief and fungal infection areas. It operates research laboratories in Kyoto and Shizuoka. Kaken Pharma is headquartered in Tokyo, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Kaken Pharmaceutical Co Ltd – Key Facts 5
Kaken Pharmaceutical Co Ltd – Key Employees 6
Kaken Pharmaceutical Co Ltd – Major Products and Services 7
Kaken Pharmaceutical Co Ltd – History 8
Kaken Pharmaceutical Co Ltd – Company Statement 10
Kaken Pharmaceutical Co Ltd – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Company Overview 12
Kaken Pharmaceutical Co Ltd – Business Description 13
R&D Overview 13
Kaken Pharmaceutical Co Ltd – SWOT Analysis 14
SWOT Analysis – Overview 14
Kaken Pharmaceutical Co Ltd – Strengths 14
Kaken Pharmaceutical Co Ltd – Weaknesses 15
Kaken Pharmaceutical Co Ltd – Opportunities 16
Kaken Pharmaceutical Co Ltd – Threats 17
Kaken Pharmaceutical Co Ltd – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Kaken Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Kaken Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Kaken Pharmaceutical Co Ltd, Recent Deals Summary 28
Section 5 – Appendix 29
Methodology 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Kaken Pharmaceutical Co Ltd, Key Facts 5
Kaken Pharmaceutical Co Ltd, Key Employees 6
Kaken Pharmaceutical Co Ltd, Major Products and Services 7
Kaken Pharmaceutical Co Ltd, History 8
Kaken Pharmaceutical Co Ltd, Subsidiaries 11
Kaken Pharmaceutical Co Ltd, Key Competitors 18
Kaken Pharmaceutical Co Ltd, Ratios based on current share price 19
Kaken Pharmaceutical Co Ltd, Annual Ratios 20
Kaken Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 21
Kaken Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 22
Kaken Pharmaceutical Co Ltd, Interim Ratios 24
Kaken Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Kaken Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Kaken Pharmaceutical Co Ltd, Recent Deals Summary 28
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32

List of Figures
Kaken Pharmaceutical Co Ltd, Performance Chart (2014 - 2018) 23
Kaken Pharmaceutical Co Ltd, Ratio Charts 25
Kaken Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Kaken Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

★海外企業調査レポート[Kaken Pharmaceutical Co Ltd (4521):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dimet (Siam) Public Company Limited (DIMET):企業概要、財務及び戦略的SWOT分析
    Summary Dimet (Siam) Public Company Limited (Dimet) is a chemical manufacturing company. The company manufactures and distributes protective coatings for refineries, power plants, oil and gas industries, offshore platforms, public utilities and other steel structure. Its product segments include pro …
  • Tongjitang Chinese Medicine Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tongjitang Chinese Medicine Com …
  • Reichhold LLC 2:企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • AcelRx Pharmaceuticals, Inc. (ACRX):(医療機器分野)企業M&A及び提携動向
    Summary AcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company. The company develops and markets therapies for the treatment of acute and breakthrough pain. Its product pipeline includes Zalviso, ARX-02, ARX-03 and ARX-04. The company’s Zalviso has completed Phase 3 development. Its produ …
  • Reliance – Anil Dhirubhai Ambani Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reliance - Anil Dhirubhai Amban …
  • Dave & Buster’s Entertainment, Inc.:企業の戦略・SWOT・財務情報
    Dave & Buster's Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dave & Buster's Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Reviva Pharmaceuticals Inc (Reviva Pharma) is a clinical development pharmaceutical company that develops therapeutic drugs. The company develops drugs in the therapeutic areas of cardiovascular, metabolic, central nervous system and inflammatory diseases. Its product pipeline comprises RP50 …
  • Red Hill Iron Limited:企業の戦略・SWOT・財務情報
    Red Hill Iron Limited - Strategy, SWOT and Corporate Finance Report Summary Red Hill Iron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PolyOne Corporation:企業の戦略・SWOT・財務分析
    SummaryPolyOne Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Cangene Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cangene Corporation Mergers and …
  • Stada Arzneimittel AG (SAZ):企業の財務及び戦略的SWOT分析
    Stada Arzneimittel AG (SAZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cash America International, Inc. (CSH):企業の財務及び戦略的SWOT分析
    Cash America International, Inc. (CSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Bolu Cimento Sanayii A.S.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bolu Cimento Sanayii A.S." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Cellceutix Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cellceutix Corporation Mergers …
  • Centrotec Sustainable AG (CEV):企業概要、財務及び戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy-competent technology product company. The company offers products in the divisions of medical technology and engineering plastics, gas flue systems and climate systems. Its products include heating systems, renewable energy, cogeneration, ven …
  • Beckman Coulter Inc-医療機器分野:企業M&A・提携分析
    Summary Beckman Coulter Inc (Beckman) is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. The company’s products are used in a wide range of …
  • Cryosite Ltd (CTE):企業の財務・戦略的SWOT分析
    Summary Cryosite Ltd (Cryosite) is a healthcare solution provider that offers clinical trials outsourced logistics services to research, medical, pharmaceutical, veterinary and biotechnology industries. The company manufactures stem cell products for both therapeutic use and clinical trials. It prov …
  • Housing Development Finance Corporation Ltd:企業のM&A・事業提携・投資動向
    Housing Development Finance Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Housing Development Finance Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • ConvaTec, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ConvaTec, Inc. Mergers and Acqu …
  • Acasti Pharma Inc. (APO):企業の財務及び戦略的SWOT分析
    Summary Acasti Pharma Inc. (Acasti) a subsidiary of Neptune Technologies & Bioressources Inc., is a biopharmaceutical company that conducts research, develops and commercializes active pharmaceutical ingredients for the management of cardiometabolic disorders. The company offers products that includ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆